Results 281 to 290 of about 197,953 (330)
Some of the next articles are maybe not open access.
Hereditary angioedema: Epidemiology and burden of disease.
Allergy and Asthma Proceedings, 2020Hereditary angioedema (HAE) is a rare autosomal dominant genetic disorder characterized by swelling of subcutaneous, mucosal, and submucosal tissue without associated pruritus or wheals caused by a temporary localized increase in vascular permeability ...
W. Lumry, R. Settipane
semanticscholar +1 more source
Hereditary Angioedema and Pregnancy
Obstetric Anesthesia Digest, 2009Background: Hereditary angioedema (HAE) is an autosomal dominant disease caused by a quantitative or functional defect in C1‐esterase inhibitor (C1‐INH). Patients with this deficiency present with episodes of angioedema which can be life‐threatening. Studies examining HAE and pregnancy are scarce with little known about the interrelationship between ...
Constance H. Katelaris +1 more
openaire +3 more sources
Efficacy and Safety of Donidalorsen for Hereditary Angioedema.
New England Journal of MedicineBACKGROUND Hereditary angioedema is a rare disorder characterized by episodic, potentially life-threatening swelling caused by kallikrein-kinin dysregulation. Long-term prophylaxis can stabilize this system.
Marc A. Riedl +17 more
semanticscholar +1 more source
Hereditary Angioedema in Pregnancy
Obstetrical & Gynecological Survey, 2021Importance Hereditary angioedema is a rare disease of potentially life-threatening attacks of angioedema that can affect patients of all ages, including women of childbearing age. Pregnancy can affect the course of the disease and the choice of treatment used. It is important for the care providers to recognize this disease and
Irene I, Chair +2 more
openaire +3 more sources
An Update on Hereditary Angioedema
Advanced Emergency Nursing Journal, 2011Hereditary angioedema affects approximately 1 in 50,000 individuals without gender or ethnic preference. Hereditary angioedema is caused by a decreased level (type I) or function (type II) of C1 inhibitor. Patients experience repeated episodes of angioedema involving sites that include the face, extremities, gastrointestinal tract, and larynx ...
Marcus Shaker, Marylee Verdi
openaire +3 more sources
Hereditary angioedema and pregnancy
The Journal of Maternal-Fetal & Neonatal Medicine, 2007Hereditary Angioedema is a rare but potentially life threatening condition. It is important that Obstetricians are aware of this condition as it affects women in the reproductive years and thus its recognition and proper management in pregnancy is crucial.
F. Khan, S. Duvvur, K. Powell
openaire +3 more sources
Hereditary and acquired angioedema
Allergy and Asthma Proceedings, 2019Hereditary angioedema (HAE) is an autosomal dominant disorder defined by a deficiency of functional C1 esterase inhibitor (C1-INH). Acquired angioedema is due to either consumption (type 1) or inactivation (type 2) of CI-INH. Both HAE and acquired angioedema can be life-threatening.
Gayatri B. Patel +1 more
openaire +3 more sources
Southern Medical Journal, 1992
Hereditary angioedema is a rare disease resulting from a lack of functional C1 esterase inhibitor (C1 INH). Several genetic defects can cause decreased production of the protein or the synthesis of a biologically inactive form. A similar, acquired condition is occasionally seen, associated with malignancies or as an autoimmune process. Disease severity
openaire +2 more sources
Hereditary angioedema is a rare disease resulting from a lack of functional C1 esterase inhibitor (C1 INH). Several genetic defects can cause decreased production of the protein or the synthesis of a biologically inactive form. A similar, acquired condition is occasionally seen, associated with malignancies or as an autoimmune process. Disease severity
openaire +2 more sources
An update on hereditary angioedema
Current Opinion in Pediatrics, 2012To review and update the management and understanding of hereditary angioedema (HAE), while integrating insights into pediatric subtleties that exist in practice.Major advances have recently been made in HAE treatment. Ecallantide (a kallikrein inhibitor approved for use in the United States in December 2009) and icatibant (a selective bradykinin B2 ...
Marcus Shaker, Derek Hsu
openaire +3 more sources
Hereditary angioedema and aortitis
Klinische Wochenschrift, 1987A 28-year-old male with hereditary angioedema died of an extensive stroke. Autopsy revealed cicatricial aortitis with narrowing of the coronary ostia, myocardial infarctions, and a left ventricular mural thrombus. There was neither acute inflammation of the aorta nor systemic vasculitis.
V Voigtlaender +5 more
openaire +2 more sources